Frederic Pouliot
Frederic Pouliot
CHU de Québec
Verified email at
Cited by
Cited by
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
RJ Motzer, B Escudier, S Oudard, TE Hutson, C Porta, S Bracarda, ...
The Lancet 372 (9637), 449-456, 2008
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
BI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...
New England Journal of Medicine 380 (12), 1116-1127, 2019
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery
K Bensalah, AJ Pantuck, N Rioux-Leclercq, R Thuret, F Montorsi, ...
European urology 57 (3), 466-473, 2010
Contemporary management of renal tumors with venous tumor thrombus
F Pouliot, B Shuch, JC LaRochelle, A Pantuck, AS Belldegrun
The Journal of urology 184 (3), 833-841, 2010
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy
J Escamilla, S Schokrpur, C Liu, SJ Priceman, D Moughon, Z Jiang, ...
Cancer research 75 (6), 950-962, 2015
Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells
F Pouliot, A Blais, C Labrie
Cancer research 63 (2), 277-281, 2003
Measurement of waist circumference: midabdominal or iliac crest?
WY Ma, CY Yang, SR Shih, HJ Hsieh, CS Hung, FC Chiu, MS Lin, PH Liu, ...
Diabetes care 36 (6), 1660-1666, 2013
Role of Smad1 and Smad4 proteins in the induction of p21 WAF1, Clp1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells
F Pouliot, C Labrie
Journal of endocrinology 172 (1), 187-198, 2002
Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma: results from cohort A of KEYNOTE-427
DF McDermott, JL Lee, C Szczylik, F Donskov, J Malik, BY Alekseev
J Clin Oncol 36 (Suppl 15), 4500, 2018
Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFβ signaling
CR Goulet, G Bernard, S Tremblay, S Chabaud, S Bolduc, F Pouliot
Molecular Cancer Research 16 (7), 1196-1204, 2018
Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1
A Blais, D Monté, F Pouliot, C Labrie
Journal of Biological Chemistry 277 (35), 31679-31693, 2002
Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts
S Couillard, C Labrie, A Bélanger, B Candas, F Pouliot, F Labrie
JNCI: Journal of the National Cancer Institute 90 (10), 772-778, 1998
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
T Azad, HJJ Van Rensburg, ED Lightbody, B Neveu, A Champagne, ...
Nature communications 9 (1), 1-15, 2018
Basic research in kidney cancer
E Oosterwijk, WK Rathmell, K Junker, AR Brannon, F Pouliot, DS Finley, ...
European urology 60 (4), 622-633, 2011
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor …
BI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...
Journal of Clinical Oncology 37 (15_suppl), 4500-4500, 2019
Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
CR Goulet, A Champagne, G Bernard, D Vandal, S Chabaud, F Pouliot, ...
BMC cancer 19 (1), 1-13, 2019
Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality?
B Shuch, PL Crispen, BC Leibovich, JC LaRochelle, F Pouliot, AJ Pantuck, ...
BJU international 107 (5), 724-728, 2011
Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens
F Pouliot, C Labrie
International journal of cancer 81 (1), 98-103, 1999
Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry
PO Richard, MAS Jewett, S Tanguay, O Saarela, ZA Liu, F Pouliot, ...
BJU international 119 (4), 543-549, 2017
First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Results from KEYNOTE-427 cohort B.
DF McDermott, JL Lee, M Ziobro, RA Gafanov, VB Matveev, C Suárez, ...
Journal of Clinical Oncology 37 (7_suppl), 546-546, 2019
The system can't perform the operation now. Try again later.
Articles 1–20